Clinical Trials Directory

Trials / Completed

CompletedNCT00783731

Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Midazolam has been used in rapid sequence intubation for a long time, and the recommended dose is 0.1mg/kg. In some studies, however, the reduced dose has been used with the concern of hemodynamic instability. We would like to investigate that the low dose midazolam could be used rather than the standard recommended dose, and also compare it to the etomidate, recently used sedatives, with respect to the side effects and the easy performance of intubation.

Conditions

Interventions

TypeNameDescription
DRUGLow dose midazolam

Timeline

Start date
2008-10-01
Primary completion
2010-10-01
Completion
2011-01-01
First posted
2008-11-03
Last updated
2011-07-26

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00783731. Inclusion in this directory is not an endorsement.